5-FU is administered intravenously (IV) as a rapid continuous bolus infusion with leucovorin (LV) or as the oral prodrug capecitabine [40], which is converted into 5-FU by the thymidine phosphorylase (TP) in tumor sites. This evidence concerns the gene TYMP and neoplasm.